Evidence-Based Complementary and Alternative Medicine / 2013 / Article / Tab 3

Research Article

Clinical Study on the Prevention of Oxaliplatin-Induced Neurotoxicity with Guilongtongluofang: Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Table 3

Objective tumor response in the trial group and the control group.

Group CR (%)PR (%)SD (%)PG (%) value

Trial group602 (3.3)24 (40.0)28 (46.7)6 (10)0.72
Control group602 (3.3)19 (31.7)32 (53.3)7 (11.7)

CR: complete response; PR: partial response; SD: stable disease; PG: progression.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.